<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC11095631</article-id>
        <article-id pub-id-type="pmcid-ver">PMC11095631.319</article-id>
        <article-id pub-id-type="pmcaid">11095631</article-id>
        <article-id pub-id-type="pmcaiid">11095631</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1984879</article-id>
        <article-id pub-id-type="pmid">37477937</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-23-1184</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1984879</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1984879</article-id>
        <article-version article-version-type="pmc-version">319</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dermawan</surname>
              <given-names initials="JK">Josephine K.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kelly</surname>
              <given-names initials="C">Ciara</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gao</surname>
              <given-names initials="Z">Zhidong</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Smith</surname>
              <given-names initials="S">Shaleigh</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Jadeja</surname>
              <given-names initials="B">Bhumika</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Singer</surname>
              <given-names initials="S">Samuel</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tap</surname>
              <given-names initials="WD">William D.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chi</surname>
              <given-names initials="P">Ping</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Antonescu</surname>
              <given-names initials="CR">Cristina R.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label> Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A2"><label>2</label> Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A3"><label>3</label> Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A4"><label>4</label> Department of Gastrointestinal Surgery, Peking University People’s Hospital, Beijing, China</aff>
        <aff id="A5"><label>5</label> Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A6"><label>6</label> Marie-Joseé and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A7"><label>7</label> Weill Cornell Medicine, New York, NY, USA</aff>
        <author-notes>
          <fn fn-type="con" id="FN1">
            <p id="P1">Authors’ Contributions</p>
            <p id="P2">JKD: conceptualization, data curation, formal analysis, data interpretation, writing and revision of the paper. CK, SS, JSS, WDT, PC: data curation, review and editing. CRA: study design and conception, data curation, analysis and interpretation of data, writing, reviewing and revision of paper. All authors read and approved the final manuscript.</p>
          </fn>
          <corresp id="CR1"><bold>Correspondence</bold>: Cristina R. Antonescu, MD, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, <email>antonesc@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN2">
            <p id="P49"><bold>Conflicts of Interest</bold>: The authors declare no conflicts of interest.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>02</day>
          <month>10</month>
          <year>2023</year>
        </pub-date>
        <volume>29</volume>
        <issue>19</issue>
        <issue-id pub-id-type="pmc-issue-id">462368</issue-id>
        <fpage>3974</fpage>
        <lpage>3985</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>02</day>
              <month>05</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>02</day>
              <month>10</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>02</day>
              <month>10</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-10-02 00:25:13.390">
              <day>02</day>
              <month>10</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1984879.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P3">Traditional risk stratification schemes in gastrointestinal stromal tumors (GIST) had been defined in the pre-imatinib era and rely solely on clinicopathologic metrics. We hypothesize that genomic-based risk stratification is prognostically relevant in the current era of tyrosine kinase inhibitor (TKI) therapeutics.</p>
          </sec>
          <sec id="S2">
            <title>Experimental Design:</title>
            <p id="P4">Comprehensive mutational and copy number profiling using MSK-IMPACT was performed. We integrated clinicopathologic and genomic parameters and utilized an elastic-net penalized Cox proportional hazards machine learning model for outcome risk stratification.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P5">A 3-tier genomic risk stratification model for recurrence-free survival (RFS) in 152 primary localized gastric and 80 small bowel GISTs was proposed. Gastric GISTs were classified as high risk if chr1p deletion or SDHB loss was present, and intermediate risk if chr14q deletion was present or <italic toggle="yes">KIT</italic> exon 11 mutation was absent. Small bowel GISTs were classified as high risk if <italic toggle="yes">MAX/MGA/MYC</italic>, <italic toggle="yes">CDKN2A</italic> or <italic toggle="yes">RB1</italic> alterations was present, and intermediate risk if chr1p deletion or chr5q amplification was present. Compared to conventional risk stratification, genomic risk stratification both upgrades and downgrades, suggesting that conventional risk stratification may underestimate or overtreat some high-risk and low-risk patients, respectively. Longitudinal sequencing detected most <italic toggle="yes">KIT-</italic>independent genomic alterations at baseline. Subanalysis in 26 SDH-deficient GISTs revealed that presence of <italic toggle="yes">TP53</italic> mutations or chr1q amplifications portends worse RFS and disease-free survival.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P6">We developed a novel, next-generation genomic risk stratification model for primary gastric and small bowel GISTs, complementing traditional clinicopathologic models. Future independent validation of our model in external cohorts is essential.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>risk stratification</kwd>
          <kwd>genomic profiling</kwd>
          <kwd>gastrointestinal stromal tumors</kwd>
          <kwd>recurrence-free survival</kwd>
          <kwd>machine learning</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
